Skip to main content
Top
Published in: Rheumatology International 2/2007

01-12-2007 | Original Article

EGF activates PI3K-Akt and NF-κB via distinct pathways in salivary epithelial cells in Sjögren’s syndrome

Authors: Hideki Nakamura, Atsushi Kawakami, Hiroaki Ida, Takehiko Koji, Katsumi Eguchi

Published in: Rheumatology International | Issue 2/2007

Login to get access

Abstract

Epidermal growth factor (EGF) exerts tropic effects on salivary epithelial cells. We examined EGF-mediated signaling pathways in the salivary epithelial cells of patients with Sjögren’s syndrome (SS). We compared the immunohistochemical expression of EGF receptor (EGF-R), phosphatidylinositol 3-kinase (PI3K), Akt and nuclear factor kappa B (NF-κB) in the labial salivary glands of SS patients (n = 6) with those of control subjects (n = 2). EGF-mediated signaling pathways were further studied in vitro (n = 3) using primary salivary epithelial cells; NF-κB p65 nuclear translocation and Akt phosphorylation were examined by immunofluorescence and western blotting, respectively. The phosphorylation of EGF-R and Akt, and the nuclear expression of NF-κB p65, were increased in situ in the salivary epithelial cells of SS patients compared with those of control subjects. Epidermal growth factor induced rapid EGF-R phosphorylation and NF-κB p65 nuclear translocation in primary salivary epithelial cells in vitro. However, EGF also induced late Akt phosphorylation (after 12 h). Chemical inhibition of PI3K-Akt by LY294002/wortmannin did not affect EGF-mediated NF-κB p65 nuclear translocation; and NF-κB inhibition by Bay 11-7082 did not suppress Akt phosphorylation. Our data suggest that EGF stimulates both the PI3K-Akt pathway and NF-κB via distinct mechanisms, promoting tropic effects in SS salivary epithelial cells.
Literature
1.
go back to reference Fox RI, Stern M, Michelson P (2000) Update in Sjögren’s syndrome. Curr Opin Rheumtol 12:391–398CrossRef Fox RI, Stern M, Michelson P (2000) Update in Sjögren’s syndrome. Curr Opin Rheumtol 12:391–398CrossRef
2.
go back to reference Kong L, Ogawa N, Nakabayashi T, Liu GT, D’Souza E, McGuff HS et al (1997) Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren’s syndrome. Arthritis Rheum 40:87–97PubMedCrossRef Kong L, Ogawa N, Nakabayashi T, Liu GT, D’Souza E, McGuff HS et al (1997) Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren’s syndrome. Arthritis Rheum 40:87–97PubMedCrossRef
3.
go back to reference Nakamura H, Koji T, Tominaga M, Kawakami A, Migita K, Kawabe Y et al (1998) Apoptosis in labial salivary glands from Sjögren’s syndrome (SS) patients: comparison with human T lymphotropic virus-I (HTLV-I)-seronegative and -seropositive SS patients. Clin Exp Immunol 114:106–112PubMedCrossRef Nakamura H, Koji T, Tominaga M, Kawakami A, Migita K, Kawabe Y et al (1998) Apoptosis in labial salivary glands from Sjögren’s syndrome (SS) patients: comparison with human T lymphotropic virus-I (HTLV-I)-seronegative and -seropositive SS patients. Clin Exp Immunol 114:106–112PubMedCrossRef
4.
go back to reference Mullighan CG, Heatley S, Lester S, Rischmueller M, Gordon TP, Bardy PG (2004) Fas gene promoter polymorphisms in primary Sjögren’s syndrome. Ann Rheum Dis 63:98–101PubMedCrossRef Mullighan CG, Heatley S, Lester S, Rischmueller M, Gordon TP, Bardy PG (2004) Fas gene promoter polymorphisms in primary Sjögren’s syndrome. Ann Rheum Dis 63:98–101PubMedCrossRef
5.
go back to reference Jonsson R, Gordon TP, Konttinen YT (2003) Recent advances in understanding molecular mechanisms in the pathogenesis and antibody profile of Sjögren’s syndrome. Curr Rheumatol Rep 5:311–316PubMedCrossRef Jonsson R, Gordon TP, Konttinen YT (2003) Recent advances in understanding molecular mechanisms in the pathogenesis and antibody profile of Sjögren’s syndrome. Curr Rheumatol Rep 5:311–316PubMedCrossRef
6.
go back to reference Ohlsson M, Szodoray P, Loro LL, Johannessen AC, Jonsson R (2002) CD40, CD154, Bax and Bcl-2 expression in Sjögren’s syndrome salivary glands: a putative anti-apoptotic role during its effector phases. Scand J Immunol 56:561–571PubMedCrossRef Ohlsson M, Szodoray P, Loro LL, Johannessen AC, Jonsson R (2002) CD40, CD154, Bax and Bcl-2 expression in Sjögren’s syndrome salivary glands: a putative anti-apoptotic role during its effector phases. Scand J Immunol 56:561–571PubMedCrossRef
7.
go back to reference Polihronis M, Tapinos NI, Theocharis SE, Economou A, Kittas C, Moutsopoulos HM (1998) Modes of epithelial cell death and repair in Sjögren’s syndrome (SS). Clin Exp Immunol 114:485–490PubMedCrossRef Polihronis M, Tapinos NI, Theocharis SE, Economou A, Kittas C, Moutsopoulos HM (1998) Modes of epithelial cell death and repair in Sjögren’s syndrome (SS). Clin Exp Immunol 114:485–490PubMedCrossRef
8.
go back to reference Yamamura Y, Onodera K, Ichinohasama R, Ooya K (2000) A histopathological study of lymphoepithelial island formation in labial salivary glands in patients with primary Sjögren’s syndrome. J Oral Pathol Med 29:110–117PubMedCrossRef Yamamura Y, Onodera K, Ichinohasama R, Ooya K (2000) A histopathological study of lymphoepithelial island formation in labial salivary glands in patients with primary Sjögren’s syndrome. J Oral Pathol Med 29:110–117PubMedCrossRef
9.
go back to reference Gorgoulis V, Giatromanolaki A, Iliopoulos A, Kanavaros P, Aninos D, Ioakeimidis D et al (1993) EGF and EGF-R immunoexpression in Sjögren’s syndrome secondary to rheumatoid arthritis. Correlation with EBV expression? Clin Exp Rheumatol 11:623–627PubMed Gorgoulis V, Giatromanolaki A, Iliopoulos A, Kanavaros P, Aninos D, Ioakeimidis D et al (1993) EGF and EGF-R immunoexpression in Sjögren’s syndrome secondary to rheumatoid arthritis. Correlation with EBV expression? Clin Exp Rheumatol 11:623–627PubMed
10.
go back to reference Anest V, Cogswell PC, Baldwin AS Jr (2004) IkappaB kinase alpha and p65/RelA contribute to optimal epidermal growth factor-induced c-fos gene expression independent of IkappaBalpha degradation. J Biol Chem 279:31183–31189PubMedCrossRef Anest V, Cogswell PC, Baldwin AS Jr (2004) IkappaB kinase alpha and p65/RelA contribute to optimal epidermal growth factor-induced c-fos gene expression independent of IkappaBalpha degradation. J Biol Chem 279:31183–31189PubMedCrossRef
11.
go back to reference Kitagawa K, Hamada Y, Kato Y, Nakai K, Nishizawa M, Ito S et al (2004) Epidermal growth factor and interleukin-1beta synergistically stimulate the production of nitric oxide in rat intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 287:G1188–G1193PubMedCrossRef Kitagawa K, Hamada Y, Kato Y, Nakai K, Nishizawa M, Ito S et al (2004) Epidermal growth factor and interleukin-1beta synergistically stimulate the production of nitric oxide in rat intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 287:G1188–G1193PubMedCrossRef
12.
go back to reference Dhar A, Young MR, Colburn NH (2002) The role of AP-1, NF-kappaB and ROS/NOS in skin carcinogenesis: the JB6 model is predictive. Mol Cell Biochem 234–235:185–193PubMedCrossRef Dhar A, Young MR, Colburn NH (2002) The role of AP-1, NF-kappaB and ROS/NOS in skin carcinogenesis: the JB6 model is predictive. Mol Cell Biochem 234–235:185–193PubMedCrossRef
13.
go back to reference Navolanic PM, Steelman LS, McCubrey JA (2003) EGFR family signaling and its association with breast cancer development and resistance to chemotherapy (Review). Int J Oncol 22:237–252PubMed Navolanic PM, Steelman LS, McCubrey JA (2003) EGFR family signaling and its association with breast cancer development and resistance to chemotherapy (Review). Int J Oncol 22:237–252PubMed
14.
go back to reference Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C (2003) PI3K/Akt and apoptosis: size matters. Oncogene 22:8983–8998PubMedCrossRef Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C (2003) PI3K/Akt and apoptosis: size matters. Oncogene 22:8983–8998PubMedCrossRef
15.
go back to reference Viatour P, Merville MP, Bours V, Chariot A (2005) Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem Sci 30:43–52PubMedCrossRef Viatour P, Merville MP, Bours V, Chariot A (2005) Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem Sci 30:43–52PubMedCrossRef
16.
go back to reference Romashkova JA, Makarov SS (1999) NF-kappaB is a target of AKT in anti-apoptotic PDGF signaling. Nature 401:86–90PubMedCrossRef Romashkova JA, Makarov SS (1999) NF-kappaB is a target of AKT in anti-apoptotic PDGF signaling. Nature 401:86–90PubMedCrossRef
17.
go back to reference Gustin JA, Ozes ON, Akca H, Pincheira R, Mayo LD, Li Q et al (2004) Cell type-specific expression of the IkappaB kinases determines the significance of phosphatidylinositol 3-kinase/Akt signaling to NF-kappa B activation. J Biol Chem 279:1615–1620PubMedCrossRef Gustin JA, Ozes ON, Akca H, Pincheira R, Mayo LD, Li Q et al (2004) Cell type-specific expression of the IkappaB kinases determines the significance of phosphatidylinositol 3-kinase/Akt signaling to NF-kappa B activation. J Biol Chem 279:1615–1620PubMedCrossRef
18.
go back to reference Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE et al (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American–European consensus group. Ann Rheum Dis 61:554–558PubMedCrossRef Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE et al (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American–European consensus group. Ann Rheum Dis 61:554–558PubMedCrossRef
19.
go back to reference Ogawa N, Ping L, Zhenjun L, Takada Y, Sugai S (2002) Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10 kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren’s syndrome. Arthritis Rheum 46:2730–2741PubMedCrossRef Ogawa N, Ping L, Zhenjun L, Takada Y, Sugai S (2002) Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10 kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren’s syndrome. Arthritis Rheum 46:2730–2741PubMedCrossRef
20.
go back to reference Ping L, Ogawa N, Sugai S (2005) Novel role of CD40 in fas-dependent apoptosis of cultured salivary epithelial cells from patients with Sjögren’s syndrome. Arthritis Rheum 52:573–581PubMedCrossRef Ping L, Ogawa N, Sugai S (2005) Novel role of CD40 in fas-dependent apoptosis of cultured salivary epithelial cells from patients with Sjögren’s syndrome. Arthritis Rheum 52:573–581PubMedCrossRef
21.
go back to reference Nakamura H, Eguchi K, Nakamura T, Mizokami A, Shirabe S, Kawakami A et al (1997) High prevalence of Sjögren’s syndrome in patients with HTLV-I associated myelopathy. Ann Rheum Dis 56:167–172PubMed Nakamura H, Eguchi K, Nakamura T, Mizokami A, Shirabe S, Kawakami A et al (1997) High prevalence of Sjögren’s syndrome in patients with HTLV-I associated myelopathy. Ann Rheum Dis 56:167–172PubMed
22.
go back to reference Nakamura H, Kawakami A, Tominaga M, Migita K, Kawabe Y, Nakamura T et al (1999) Expression of CD40/CD40 ligand and Bcl-2 family proteins in labial salivary glands of patients with Sjögren’s syndrome. Lab Invest 79:261–269PubMed Nakamura H, Kawakami A, Tominaga M, Migita K, Kawabe Y, Nakamura T et al (1999) Expression of CD40/CD40 ligand and Bcl-2 family proteins in labial salivary glands of patients with Sjögren’s syndrome. Lab Invest 79:261–269PubMed
23.
go back to reference Matsumura R, Kagami M, Tomioka H, Tanabe E, Sugiyama T, Sueishi M et al (1996) Expression of ductal Fas antigen in sialoadenitis of Sjögren’s syndrome. Clin Exp Rheumatol 14:309–311PubMed Matsumura R, Kagami M, Tomioka H, Tanabe E, Sugiyama T, Sueishi M et al (1996) Expression of ductal Fas antigen in sialoadenitis of Sjögren’s syndrome. Clin Exp Rheumatol 14:309–311PubMed
24.
go back to reference Ahn JY, Rong R, Liu X, Ye K (2004) PIKE/nuclear PI 3-kinase signaling mediates the antiapoptotic actions of NGF in the nucleus. EMBO J 23:3995–4006PubMedCrossRef Ahn JY, Rong R, Liu X, Ye K (2004) PIKE/nuclear PI 3-kinase signaling mediates the antiapoptotic actions of NGF in the nucleus. EMBO J 23:3995–4006PubMedCrossRef
25.
go back to reference Keates S, Keates AC, Katchar K, Peek RM Jr, Kelly CP (2007) Helicobacter pylori Induces up-regulation of the epidermal growth factor receptor in AGS gastric epithelial cells. J Infect Dis. 196:95–103PubMedCrossRef Keates S, Keates AC, Katchar K, Peek RM Jr, Kelly CP (2007) Helicobacter pylori Induces up-regulation of the epidermal growth factor receptor in AGS gastric epithelial cells. J Infect Dis. 196:95–103PubMedCrossRef
26.
go back to reference Nakamura H, Kawakami A, Yamasaki S, Kawabe Y, Nakamura T, Eguchi K (1999) Expression of mitogen activated protein kinases in labial salivary glands of patients with Sjögren’s syndrome. Ann Rheum Dis. 58:382–385PubMedCrossRef Nakamura H, Kawakami A, Yamasaki S, Kawabe Y, Nakamura T, Eguchi K (1999) Expression of mitogen activated protein kinases in labial salivary glands of patients with Sjögren’s syndrome. Ann Rheum Dis. 58:382–385PubMedCrossRef
27.
go back to reference Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB (1999) NF-kappaB activation by tumor necrosis factor requires the Akt serine-threonine kinase. Nature 401:82–85PubMedCrossRef Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB (1999) NF-kappaB activation by tumor necrosis factor requires the Akt serine-threonine kinase. Nature 401:82–85PubMedCrossRef
28.
go back to reference Dhawan P, Singh AB, Ellis DL, Richmond A (2002) Constitutive activation of Akt/protein kinase B in melanoma leads to up-regulation of nuclear factor-kappaB and tumor progression. Cancer Res 62:7335–7442PubMed Dhawan P, Singh AB, Ellis DL, Richmond A (2002) Constitutive activation of Akt/protein kinase B in melanoma leads to up-regulation of nuclear factor-kappaB and tumor progression. Cancer Res 62:7335–7442PubMed
29.
go back to reference Kao SJ, Lei HC, Kuo CT, Chang MS, Chen BC, Chang YC et al (2005) Lipoteichoic acid induces nuclear factor-kappaB activation and nitric oxide synthase expression via phosphatidylinositol 3-kinase, Akt, and p38 MAPK in RAW 264.7 macrophages. Immunology 115:366–374PubMedCrossRef Kao SJ, Lei HC, Kuo CT, Chang MS, Chen BC, Chang YC et al (2005) Lipoteichoic acid induces nuclear factor-kappaB activation and nitric oxide synthase expression via phosphatidylinositol 3-kinase, Akt, and p38 MAPK in RAW 264.7 macrophages. Immunology 115:366–374PubMedCrossRef
30.
go back to reference Meng F, Liu L, Chin PC, D’Mello SR (2002) Akt is a downstream target of NF-kappa B. J Biol Chem 277:29674–29680PubMedCrossRef Meng F, Liu L, Chin PC, D’Mello SR (2002) Akt is a downstream target of NF-kappa B. J Biol Chem 277:29674–29680PubMedCrossRef
31.
go back to reference Wang HQ, Quan T, He T, Franke TF, Voorhees JJ, Fisher GJ (2003) Epidermal growth factor receptor-dependent, NF-kappaB-independent activation of the phosphatidylinositol 3-kinase/Akt pathway inhibits ultraviolet irradiation-induced caspases-3, -8, and -9 in human keratinocytes. J Biol Chem 278:45737–45745PubMedCrossRef Wang HQ, Quan T, He T, Franke TF, Voorhees JJ, Fisher GJ (2003) Epidermal growth factor receptor-dependent, NF-kappaB-independent activation of the phosphatidylinositol 3-kinase/Akt pathway inhibits ultraviolet irradiation-induced caspases-3, -8, and -9 in human keratinocytes. J Biol Chem 278:45737–45745PubMedCrossRef
32.
go back to reference Ackland ML, Newgreen DF, Fridman M, Waltham MC, Arvanitis A, Minichiello J et al (2003) Epidermal growth factor-induced epithelio-mesenchymal transition in human breast carcinoma cells. Lab Invest 83:435–448PubMed Ackland ML, Newgreen DF, Fridman M, Waltham MC, Arvanitis A, Minichiello J et al (2003) Epidermal growth factor-induced epithelio-mesenchymal transition in human breast carcinoma cells. Lab Invest 83:435–448PubMed
33.
go back to reference Nakamura H, Kawakami A, Ida H, Koji T, Eguchi K. Epidermal growth factor inhibits Fas-mediated apoptosis in salivary epithelial cells of patients with Sjögren’s syndrome accepted in Clin Exp Rheumatol Nakamura H, Kawakami A, Ida H, Koji T, Eguchi K. Epidermal growth factor inhibits Fas-mediated apoptosis in salivary epithelial cells of patients with Sjögren’s syndrome accepted in Clin Exp Rheumatol
Metadata
Title
EGF activates PI3K-Akt and NF-κB via distinct pathways in salivary epithelial cells in Sjögren’s syndrome
Authors
Hideki Nakamura
Atsushi Kawakami
Hiroaki Ida
Takehiko Koji
Katsumi Eguchi
Publication date
01-12-2007
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 2/2007
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-007-0411-9

Other articles of this Issue 2/2007

Rheumatology International 2/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine